ArticleScientific reports2025
Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma.
Hongbing Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it